Tekla Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Tekla Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,792	Closed	-$2.63M	–	197
2021 Q1	$2.63M	Sell	12,792 -5,324	-29%	-$1.16M	0.09%	151
2020 Q4	$3.62M	Hold	18,116	–	–	0.13%	135
2020 Q3	$3M	Hold	18,116	–	–	0.11%	132
2020 Q2	$4.49M	Hold	18,116	–	–	0.17%	109
2020 Q1	$3.3M	Hold	18,116	–	–	0.15%	109
2019 Q4	$5.25M	Hold	18,116	–	–	0.2%	100
2019 Q3	$4.94M	Hold	18,116	–	–	0.22%	85
2019 Q2	$6.81M	Sell	18,116 -7,976	-31%	-$2.38M	0.28%	77
2019 Q1	$6.99M	Hold	26,092	–	–	0.28%	75
2018 Q4	$5.55M	Hold	26,092	–	–	0.24%	80
2018 Q3	$11.7M	Hold	26,092	–	–	0.42%	54
2018 Q2	$10.6M	Hold	26,092	–	–	0.4%	57
2018 Q1	$14.2M	Buy	26,092 +1,562	+6%	+$967K	0.55%	41
2017 Q4	$14.8M	Sell	24,530 -10,940	-31%	-$5.09M	0.57%	38
2017 Q3	$16.3M	Hold	35,470	–	–	0.58%	36
2017 Q2	$14.4M	Sell	35,470 -13,781	-28%	-$4.03M	0.53%	40
2017 Q1	$10.2M	Sell	49,251 -2,573	-5%	-$455K	0.4%	55
2016 Q4	$5.8M	Hold	51,824	–	–	0.25%	72
2016 Q3	$7.59M	Buy	51,824 +3,722	+8%	+$495K	0.29%	70
2016 Q2	$6.2M	Hold	48,102	–	–	0.25%	80
2016 Q1	$7.31M	Hold	48,102	–	–	0.31%	69
2015 Q4	$8.81M	Hold	48,102	–	–	0.32%	67
2015 Q3	$7.04M	Hold	48,102	–	–	0.25%	87
2015 Q2	$10.6M	Buy	+48,102	New	+$10.6M	0.38%	58

Other funds holding PVLA

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tekla Capital Management's PVLA Position: Q2 2021 in Review

Tekla Capital Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 12,792 shares — an estimated $2.63M sold.

Tekla Capital Management first reported a position in PVLA in Q2 2015 and held it in 24 quarters. The position peaked at $16.3M in Q3 2017. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

Tekla Capital Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
Tekla Capital Management sold 12,792 Palvella Therapeutics shares in Q2 2021, an estimated $2.63M.
Tekla Capital Management first reported a position in Palvella Therapeutics in Q2 2015 and held it in 24 quarters.
Tekla Capital Management's Palvella Therapeutics position peaked at $16.3M in Q3 2017.
73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on Tekla Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.